Name: EUDAW Income Statement - Euda Health Holdings. Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

EUDAW - Euda Health Holdings. Ltd.

USD | NASDAQ | Healthcare

EUDAW Income Statement - Euda Health Holdings. Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 23	Q4 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q2 FY 21
Revenues
Revenues	1.7	-	-	2.7	-	-
Cost of Revenue	1.3	-	-	1.4	-	-
Gross Profit	0.4	-	-	1.3	-	-
Operating Expenses
Research & Development	-	-	-	0.0	-	-
Selling General & Administrative	-	-	-	-	-	-
Operating Income
Operating Income	(2.0)	(0.3)	(0.5)	0.1	(0.0)	(0.0)
Non-Operating
Interest Income	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-
Income From Equity Investments
Tax & Net
Income Tax Expense	0.0	-	-	0.0	-	-
Net Income From Continuing Ops	(0.6)	0.2	(0.5)	0.2	(0.0)	(0.0)
Net Income From Discontinued Ops
Per Share
EPS Basic	(0.12)	-	-	0.02	-	-
EPS Diluted	(0.12)	-	-	0.02	-	-
Shares Basic
Supplementary Data
EBITDA	(2.0)	-	-	0.1	-	-
EBIT	(2.0)	(0.3)	(0.5)	0.1	(0.0)	(0.0)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021
Revenues
Revenues	-	6.8	4.0	3.7	3.8	4.6
Cost of Revenue	-	3.8	3.2	2.9	2.9	3.3
Gross Profit	-	3.0	0.8	0.8	0.9	1.2
Operating Expenses
Research & Development	-	0.0	-	-	0.0	0.1
Selling General & Administrative	-	-	-	-	-	-
Operating Income
Operating Income	(2.7)	(2.5)	(17.3)	(4.0)	(12.2)	(0.6)
Non-Operating
Interest Income	-	-	-	-	-	-
Interest Expense	-	0.2	0.0	0.0	-	-
Income From Equity Investments
Tax & Net
Income Tax Expense	-	0.0	(0.0)	-	(0.0)	0.0
Net Income From Continuing Ops	(0.7)	(2.8)	(17.6)	(8.4)	(25.0)	1.6
Net Income From Discontinued Ops
Per Share
EPS Basic	(0.12)	(1.48)	(9.46)	(8.77)	(2.07)	0.09
EPS Diluted	(0.12)	(1.48)	(9.46)	(8.77)	(2.07)	0.09
Shares Basic
Supplementary Data
EBITDA	-	(2.3)	(17.2)	(3.8)	(12.0)	(0.6)
EBIT	(2.7)	(2.5)	(17.3)	(4.0)	(12.2)	(0.6)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)